Abstract
Gliotoxin is a fungal metabolite that has immunosuppressive properties. First, we determined if gliotoxin could inhibit cytokine production from macrophage and colonic epithelial cell lines, as well as whether it inhibited nuclear factor-kappa B in these same cell types. Second, we evaluated whether gliotoxin could reduce dextran sodium sulfate-induced colitis in rats. A disease activity index, myeloperoxidase activity, and cytokine levels were evaluated on either day 7 or 21. In both cell lines, gliotoxin dose dependently inhibited cytokine production and nuclear factor-kappa B. On day 21, gliotoxin significantly reduced disease activity (diarrhea and bloody stools) in rats. On day 7, gliotoxin treatment significantly improved various indices of colitis, including colonic cytokine levels. Decreased food consumption and weight gain was evident with a larger dose of gliotoxin. In summary, gliotoxin, a nuclear factor-kappa B inhibitor, effectively reduced dextran sodium sulfate-induced colitis in rats. However, gliotoxin exhibited a narrow therapeutic to toxicity ratio in these rats.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Waring P, Beaver J: Gliotoxin and related epipolythiodioxopiperazines. Gen Pharmacol 27:1311-1316, 1996
Eichner RD, Al Salami M, Wood PR, Mullbacher A: The effect of gliotoxin upon macrophage function. Int J Immunopharmacol 8:789-797, 1986
Waring P, Eichner RD, Mullbacher A, Sjaarda A: Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem 263:18493-18499, 1988
Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C, Rossi AG: NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 274:4309-4318, 1999
Pahl HL, Kraub B, Schulze-Osthoff K, Decker T, Traenckner EBM, Vogt M, Myers C, Parks T, Waring P, Mullbacher A, Czernilofsky AP, Baeuerle PA: The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J Exp Med 183:1829-1840, 1996
Sutton P, Newcombe NR, Waring P, Mullbacher A: In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun 62:1192-1198, 1994
Kroll M, Arenzana-Seisdedos F, Bachelerie F, Thomas D, Friguet B, Conconi M: The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem Biol 6:689-698, 1999
Herfarth H, Rath HC, Hofmeister R, Rogler G, Brand K, Scholmerich J, Falk W: In vivo treatment with the fungal metabolite gliotoxin suppresses intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis. Gastroenterology 114:A993, 1998
Herfarth H, Brand K, Rogler G, Falk W: Immunosuppressive effect of treatment with the fungal metabolite gliotoxin in dextran sulphate sodium (DSS)-induced colitis. Gastroenterology 116:A735, 1999
Herfarth H, Brand K, Rath HC, Rogler G, Schlomerich J, Falk W: Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol 120:59-65, 2000
Kijatima S, Takuma S, Morimoto M: Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine-DSS-induced colitis. J Vet Med Sci 61:67-70, 1999
Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Kelbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD: A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104:383-389, 1999
Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeurle PA, Scholmerich J, Gross V: Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115:357-369, 1998
Murthy SNS, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sendergran DJ: Treatment of dextran sulfate sodium-induced murine colitis by intacolonic cyclosporin. Dig Dis Sci 38:1722-1734, 1993
Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T: Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 132:345-352, 1983
Santucci L, Fiorucci S, Di Matteo FM, Morelli A: Role of tumor necrosis factor α release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 108:393-401, 1995
Barnes PJ, Karin M: Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
Plumpe J, Malek NP, Thomas-Bock C, Rakemann T, Manns MP, Trautwein C: NF-κB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol (Gastrointest Liver Physiol) 278:G173-G183, 2000
Fitzpatrick LR, Williams J, Le T: Characterization of the reactivation phase of dextran sodium sulfate (DSS)-induced colitis in rats. Gastroenterology 114:A976, 1998
Braithwaite AW, Eichner RD, Waring P, Mullbacher A: The immunomodulating agent gliotoxin causes genomic DNA fragmentation. Mol Immun 24:47-55, 1987
Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
Yang F, De Villiers JS, Lee EY, McClain CJ, Varilek GW: Increased nuclear factor-kappa B activation in colitis of interleukin-2-deficient mice. J Lab Clin Med 134:378-385, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fitzpatrick, L.R., Wang, J. & Le, T. In Vitro and In Vivo Effects of Gliotoxin, a Fungal Metabolite:. Dig Dis Sci 45, 2327–2336 (2000). https://doi.org/10.1023/A:1005630723111
Issue Date:
DOI: https://doi.org/10.1023/A:1005630723111